intravascular hemolysis

Related by string. * Intravascular : angiography intravascular ultrasound IVUS . disseminated intravascular coagulation . intravascular ultrasound IVUS . Intravascular Ultrasound IVUS . intravascular ultrasonography . intravascular ultrasound . intravascular imaging . intravascular temperature . Intravascular Ultrasound / Hemolysis : chronic hemolysis . hemolysis * *

Related by context. All words. (Click for frequent words.) 74 Ribavirin causes 73 hyperphenylalaninemia HPA due 73 Erythropoietic therapies may 72 lactate dehydrogenase LDH 71 receiving XGEVA 71 deep venous thromboses 71 anemia thrombocytopenia 71 haematologic 71 symptomatic intracranial 71 pancytopenia 71 Hypotension 70 nephrotoxicity 70 aminotransferases 70 morphometric vertebral fractures 70 pulmonary infiltrates 70 Hepatotoxicity 70 receiving VELCADE 70 venous thromboembolic disease 70 Known hypersensitivity 70 hepatocellular 70 serum phosphate 69 CYT# potent vascular disrupting 69 liver decompensation 69 aminotransferase ALT 69 fibrin deposition 69 included exfoliative dermatitis 69 cytopenias 69 dermatologic reactions 69 serum aminotransferase levels 69 neutropenia dehydration dyspnea 69 kidney urologic 69 myocardial necrosis 69 delayed CINV 69 intraocular pressure IOP 69 metastatic neuroendocrine tumors 69 eculizumab therapy 69 riociguat 68 Tasigna prolongs 68 Primary Hypercholesterolemia 68 psoriatic arthritis PsA 68 gastrointestinal mucositis 68 SGPT 68 PLX STROKE targeting 68 elevated transaminases 68 hypoperfusion 68 ischemia induced 68 nasopharyngitis headache 68 symptomatic VTE 68 artery stenosis 68 alanine aminotransferase 68 cytomegalovirus infection 68 lactate dehydrogenase 68 viral titers 68 papilledema 68 complement inhibitor eculizumab 68 headache abdominal pain 68 dual endothelin receptor antagonist 68 myeloperoxidase 68 tryptase 68 leucopenia 68 Tumor shrinkage 68 induce orthostatic hypotension 68 PASI scores 68 tumor necrosis 68 myocardial infarction ventricular fibrillation 68 eosinophilia 68 MS relapses 68 syncope fainting 68 demonstrated antitumor activity 68 hyperprolactinemia 68 Catheter Associated 68 Infusion Reactions Severe 68 hemodilution 68 Hematologic 68 Amgen Neulasta R 68 variant angina 68 fatigue diarrhea nausea 68 hematological parameters 68 lymphoproliferative disorder 68 vitreous floaters 68 intracranial hemorrhage ICH 68 cerebral ischemia 68 elevated ALT 68 HER2 overexpression 68 cytopenia 67 chronic thromboembolic pulmonary 67 colorectal adenoma 67 NSAID induced 67 prolonged QT interval 67 acute hepatic 67 keloid scarring 67 parkinsonian symptoms 67 recurrent venous thromboembolism 67 myocardial reperfusion 67 either acutely decompensated 67 intracranial hypertension 67 R Saizen R 67 vasodilatation 67 torsade de pointes 67 steroid refractory 67 renal toxicity 67 oral prodrug 67 bronchial hyperresponsiveness 67 fatigue abdominal pain 67 lymphopenia 67 tissue oxygenation 67 left ventricular diastolic 67 STRIDE PD 67 myelodysplastic myeloproliferative diseases 67 myoclonus 67 hypophosphatemia 67 diabetic kidney 67 antitumor efficacy 67 refractory gout 67 bone marrow reticulin deposition 67 Severe hypoglycemia 67 Febrile neutropenia 67 recurrent glioblastoma multiforme 67 AA Amyloidosis 67 autoantibody levels 67 serum urate levels 67 fatigue nausea vomiting 67 foveal thickness 67 ventricular tachyarrhythmia 67 severe hypersensitivity reactions 67 leukocytosis 67 hematological toxicity 67 thyrotoxicosis 67 vaso occlusive crisis 67 Oral Fingolimod 67 hepatic fibrosis 67 recurrent DVT 67 Enzastaurin 67 CYP#A# substrate 67 pyrexia mucositis sepsis febrile 67 atherogenic dyslipidemia 67 natriuresis 67 VEGF induced 67 hemorrhagic complications 67 thrombotic complications 67 capillary leakage 67 reactogenicity 67 inducible nitric oxide synthase 67 Estrogen deficiency 67 blood phenylalanine Phe 67 Intravenous immunoglobulin 67 relapsed MM 67 elevated prolactin 67 mucosal inflammation 67 OAB symptoms 67 hyperammonemia 67 CP CPPS 67 heparin induced thrombocytopenia 67 PAOD 66 transfusion syndrome 66 SIADH 66 headache nasopharyngitis 66 lumbar disk herniation 66 experimentally induced 66 HER2 expression 66 aspartate aminotransferase AST 66 J. Clin 66 glycosylated hemoglobin HbA1c 66 ID TLR 66 angioneurotic edema 66 clinically meaningful reductions 66 postoperative AF 66 extrapyramidal symptoms 66 HeFH 66 colorectal carcinoma 66 thrombocytopenia neutropenia 66 R lenalidomide 66 liver transaminases 66 intracerebral haemorrhage 66 bacterial prostatitis 66 hyperalgesia 66 antiphospholipid syndrome 66 postoperative mortality 66 serum calcium levels 66 BARACLUDE ® 66 demonstrated clinically meaningful 66 myopathy rhabdomyolysis 66 glomerular filtration 66 moderate renal impairment 66 taxane resistant 66 Nebulized 66 cholestasis 66 atrial tachyarrhythmias 66 CIMZIA ™ 66 Relapsing Remitting Multiple Sclerosis 66 systemic hypotension 66 liver histology 66 neutropenia thrombocytopenia 66 novel VDA molecule 66 denileukin diftitox 66 Chemotherapy induced 66 lung fibrosis 66 serum phosphorous 66 Warfarin Coumadin 66 cervicitis 66 esophagogastric 66 post surgical adhesions 66 capillary leak 66 cerebral oxygenation 66 coagulopathy 66 embolic stroke 66 FUSILEV enhances 66 diabetic polyneuropathy 66 somnolence fatigue 66 Postoperative 66 EDARBI 66 neutrophil counts 66 intraoperative complications 66 HIV HCV coinfected 66 Diabetic neuropathy 66 AGILECT R 66 ACTEMRA TM 66 pulmonary alveolar 66 hepatic enzymes 66 radiographic findings 66 AST ALT 66 pseudoaneurysm 66 rheumatoid arthritis osteoarthritis ankylosing 66 peripheral neuropathy CIPN 66 inhaled iloprost 66 cardiac repolarization 66 CTAP# Capsules 66 gastric carcinoma 66 electrolyte abnormalities 66 lens opacities 66 hemodynamically stable 66 endotoxin induced 66 platelet reactivity 66 postoperative morbidity 66 bone marrow suppression 66 GI bleeds 66 moderate hepatic impairment 66 retinal vein occlusion induced 66 atrioventricular block 66 dysrhythmias 66 skeletal metastases 66 proliferative diabetic retinopathy 66 ecchymosis 66 anemia hemoglobin 66 colorectal adenocarcinoma 66 LVNC 66 hypercalcaemia 66 overt nephropathy 66 akinesia 66 neurocognitive deficits 66 oral FTY# 66 Proteinuria 66 lymphomas leukemias 66 CIPN 66 epithelial tumors 66 sitaxsentan 66 cerebral vasospasm 66 draining enterocutaneous 66 urticaria hives 66 Angioedema 66 gastro esophageal reflux 66 serum bicarbonate 66 CIMZIA TM certolizumab pegol 66 allograft rejection 65 hemorrhagic cystitis 65 hemolysis 65 antibody mediated 65 Thromboembolic 65 acromegalic patients 65 vesicoureteral reflux 65 pulmonary inflammation 65 enlarged spleens 65 pathophysiological effects 65 fosbretabulin 65 unresectable HCC 65 gastrointestinal GI perforation 65 Occlusive Disease 65 alanine aminotransferase ALT 65 gastrointestinal toxicities 65 AVAPRO 65 vascular reactivity 65 bullous 65 Severe cutaneous 65 TNF Tumor Necrosis Factor 65 neurologic complications 65 postoperative inflammation 65 Reversible Posterior Leukoencephalopathy Syndrome 65 EXJADE 65 invasive candidiasis 65 CYP#A# CYP#D# 65 obstructive coronary 65 chronic eosinophilic leukemia 65 metastatic malignant 65 activated partial thromboplastin 65 Tumor Response 65 diarrhea dyspepsia 65 angiotensin analog 65 PSA nadir 65 parasitemia 65 thrombocytosis 65 Toxicities 65 Antitumor Activity 65 Thrombotic thromboembolic complications 65 #q# deletion syndrome 65 idiopathic thrombocytopenic purpura ITP 65 diarrhea abdominal 65 anterior uveitis 65 hematologic toxicity 65 oral antidiabetic medication 65 perioperatively 65 recurrent ischemia 65 plasma creatinine 65 Atypical Hemolytic Uremic Syndrome 65 lichen planus 65 microvascular complications 65 levodopa induced 65 gastric adenocarcinoma 65 NAGS deficiency 65 pruritus rash 65 pulmonary toxicity 65 parathyroid carcinoma 65 neurologic dysfunction 65 spirometric 65 Stent thrombosis 65 glycosylated hemoglobin levels 65 TNF antagonist 65 Non inferiority 65 bleeding pallor 65 bronchoalveolar lavage 65 constipation nausea 65 aspartate aminotransferase 65 factor PlGF 65 venous stasis ulcers 65 peripheral arterial occlusive disease 65 coagulation parameters 65 interleukin IL -# 65 immunoreactivity 65 Neutropenia 65 Demonstrates Positive 65 mu opioid receptor antagonist 65 hematologic parameters 65 phototoxicity 65 adrenocortical cancer 65 prolonged cytopenias 65 Asymptomatic 65 CD# expression [001] 65 XP# Transported Prodrug 65 preterm neonates 65 somnolence dizziness 65 PRADAXA #mg 65 cardiac dysfunction 65 TO AVOID PREGNANCY WHILE 65 pharmacodynamic parameters 65 erythema nodosum 65 intracoronary 65 antigen PSA levels 65 mitoxantrone plus 65 recurrent malignant glioma 65 microglial activation 65 renal scarring 65 elevated creatinine 65 Postoperatively 65 radiotherapy RT 65 plasma triglycerides 65 QT interval prolongation 65 hepatic liver 65 LPS induced 65 transaminase elevations 65 ® lenalidomide 65 Exacerbations 65 Clinically significant 65 VEGF expression 65 agitation hallucinations 65 dopaminergic therapy 65 perfusion defects 65 Akt activation 65 neointimal hyperplasia 65 HBV infections 65 anaphylactic reactions bronchospasm 65 orthostatic blood 65 IL 1ß 65 hemodynamic measurements 65 metabolic alkalosis 65 serologically active systemic lupus 65 cervical lymph nodes 65 Thrombocytopenia 65 postoperative pulmonary 65 myoglobinuria rhabdomyolysis 65 thrombocytopenic 65 endotoxemia 65 upper gastrointestinal bleeding 65 gross hematuria 65 basal bolus regimen 65 catheter occlusion 65 relapsing remitting MS RRMS 65 INCB# [003] 65 Ischemic 65 neurosensory 65 unstable angina pectoris 65 gadolinium enhanced 65 serum cortisol 65 extracranial 65 anaphylaxis dyspnea flushing 65 tumor lysis syndrome 65 Pharmacodynamic 65 acetonide FA 65 lymph node enlargement 65 Viral load 65 clevidipine 65 HBeAg 65 coadministration 65 Acute Ischemic Stroke 65 acute humoral rejection 65 antiangiogenic activity 65 unresectable tumors 65 desvenlafaxine succinate 65 prospective multicenter study 65 neovascularisation 65 CIN3 65 keloid scarring treatment 65 elevated serum creatinine 65 evaluating tivozanib 65 esophageal reflux 65 idiopathic Parkinson disease 65 imatinib therapy 65 erythropoietic 65 hypereosinophilic syndrome 65 NSAID associated 65 endothelial activation 65 intracranial bleeding 65 brand ciclesonide HFA 65 Secondary Hyperparathyroidism 64 ischemic cardiac 64 SSc 64 chronic idiopathic thrombocytopenic purpura 64 interleukin IL -6 64 Parathyroid hormone 64 airway hyperresponsiveness 64 haemolysis 64 hypervascular tumors 64 intratumoral 64 surgical prophylaxis 64 achieved CCyR 64 Microplasmin 64 ara C 64 TMS Therapy 64 dizziness numbness 64 fibrotic disease 64 Urinary tract 64 hepatic arterial 64 induced ischemia 64 gastroduodenal 64 atrophic gastritis 64 p# alpha [001] 64 quetiapine XR 64 hyperresponsiveness 64 Randomized Double blind 64 dizziness headache nausea 64 neuritic 64 TNFalpha 64 ventricular remodeling 64 rosuvastatin #mg 64 Renal impairment 64 overt hepatic encephalopathy HE 64 aMCI precursor 64 paricalcitol 64 tumoral 64 vein thrombosis 64 Xelox 64 E selectin 64 Magnesium deficiency 64 NIASPAN 64 diarrhea headache nausea 64 NSAID induced GI 64 reinfarction 64 thyroid carcinoma 64 clinically meaningful improvements 64 neovascular 64 hepatic enzyme 64 macrovascular events 64 Ileus 64 sweat chloride 64 hypothalamic pituitary adrenal axis 64 glycated hemoglobin HbA1c 64 ALB # 64 receptor tyrosine kinase inhibitor 64 lymphadenopathy 64 pulmonary metastases 64 SGOT 64 Histologic 64 fast skeletal troponin 64 cisplatin gemcitabine 64 OMNARIS HFA 64 bone marrow reticulin 64 asthenia fatigue 64 tumorigenicity 64 mixed hyperlipidemia 64 postsurgical pain 64 Veno Occlusive Disease 64 esophageal carcinoma 64 MYCAMINE 64 Kinoid 64 papillary renal cell carcinoma 64 MCyR 64 intimal hyperplasia 64 thrombo embolic 64 Hypercholesterolemia 64 severe exacerbations 64 tipranavir r 64 cardiac troponin 64 containing abacavir 64 BMPR2 64 Secondary endpoints include 64 hepatorenal syndrome 64 prospectively stratified 64 Chronic pancreatitis 64 metabolic acidosis 64 pulmonary capillary wedge 64 neurologic symptoms 64 colic diarrhea 64 R Bortezomib 64 corticosteroid dose 64 HMG CoA reductase inhibitors 64 leukoencephalopathy 64 Microalbuminuria 64 teriflunomide 64 severe hepatic dysfunction 64 GOUT 64 bacteriuria 64 CMV infections 64 microvessel density 64 Subgroup analysis 64 gastric varices 64 ischemia reperfusion 64 coagulation abnormalities 64 hyperbilirubinemia 64 cobiprostone 64 paralytic ileus 64 fatal anaphylactic 64 myocardial function 64 osteoporotic vertebral compression fractures 64 allogeneic HSCT 64 selective modulator 64 receptor inhibitor 64 severe oral mucositis 64 nicardipine 64 CTEPH 64 frequent awakenings 64 neutropaenia 64 primary hyperparathyroidism 64 diabetic gastroparesis 64 Adenomas 64 leukocyte adhesion 64 bardoxolone methyl 64 paclitaxel cisplatin 64 ANCA associated 64 glycated hemoglobin levels 64 silent ischemia 64 proctitis 64 cough wheezing 64 Skin sterol 64 myocardial ischemia 64 thromboembolic disease 64 myocardial ischaemia 64 Nausea vomiting 64 Aggrastat ® tirofiban hydrochloride 64 Hemolysis 64 Patients Receiving 64 alfuzosin 64 trial evaluating PRX# 64 hepatic function 64 ovarian suppression 64 pulmonary exacerbations 64 pyridostigmine 64 nausea vomiting headache 64 tardive dyskinesia TD 64 hypomagnesemia 64 chronic renal disease 64 cTnI 64 TTF Therapy 64 LHRH receptor positive 64 nonhematologic adverse reactions 64 plasma kallikrein inhibitor 64 perioperative complications 64 postoperative atrial fibrillation 64 Castration Resistant Prostate Cancer 64 variceal bleeding 64 idiopathic pulmonary 64 Natalizumab 64 brachial artery flow 64 Secondary endpoints included 64 rectovaginal fistulas 64 thetreatment 64 Hepatocellular Carcinoma HCC 64 acute ischemia 64 cervical anal 64 TNF alpha selectively neutralizing 64 methicillin susceptible Staphylococcus aureus 64 underlying vasculopathy 64 pulmonary metastasis 64 pulmonary artery hypertension 64 INVEGA ® 64 NMDA antagonists 64 primidone 64 cough dyspnea 64 SNT-MC#/idebenone 64 Improves Outcomes 64 coughing fatigue emaciation 64 dysplastic lesions 64 protein excretion 64 MDS MPD 64 impaired cognition 64 leukocyte counts 64 canakinumab 64 plus methotrexate 64 Abrupt discontinuation 64 corticosteroid therapy 64 p# activation 64 hypocalcaemia 64 Alequel 64 lymphocytosis 64 tracer uptake 64 QTc intervals 64 troponin T 64 prostate abnormalities 64 nonfatal myocardial infarction MI 64 hypercholesterolaemia 64 choroidal neovascularization 64 rebleeding 64 atelectasis 64 PEGylated anti 64 metaglidasen 64 mucocutaneous reactions 64 synovial fibroblasts 64 neurocognitive outcomes 64 SPRYCEL ® 64 osteoclastic 64 myeloid metaplasia 64 specific antigen PSA 64 inflamed tissues 64 duplex ultrasonography 64 INTEGRILIN R 64 cardiac tamponade cerebral edema 64 FDG uptake 64 occlusive disease 64 interstitial fibrosis 64 serum potassium 64 hemolytic 64 S. aureus colonization 64 transthyretin TTR mediated amyloidosis 64 tachyarrhythmias 64 COPEGUS therapy 64 MALT lymphoma 64 dermopathy 64 FVIII inhibitors 64 Eculizumab 64 Forodesine HCl 64 renal flares 64 leukemia AML 64 Sleep disturbances 64 treat benign prostatic 64 Nonspecific 64 echocardiographic parameters 64 neurologic progression 64 ileus 64 pressure natriuresis 64 antithrombotic therapy 64 ALT AST 64 inotropic 63 MGd 63 syndrome OSAS 63 mania hypomania 63 osteolytic 63 Renal Impairment 63 hyperreflexia 63 anemia neutropenia 63 swelling stiffness 63 autonomic dysfunction 63 urolithiasis 63 intra abdominal abscess 63 Virological 63 bisoprolol 63 QTc prolongation 63 invasive aspergillosis 63 HBeAg seroconversion 63 reduce serum phosphate 63 Epstein Barr Virus EBV 63 acute GvHD 63 overactive bladder syndrome 63 chloride secretion 63 r hGH 63 endometrial hyperplasia 63 Stomatitis 63 Vascugel ® 63 Akt phosphorylation 63 fibrosis scarring 63 cardiovascular cerebrovascular 63 thromboembolic complications 63 haematopoietic 63 lesional 63 gastro oesophageal reflux 63 untreated OSA 63 CXB# 63 HuMax EGFr 63 REMINYL ® 63 virological response 63 NAbs 63 systemic amyloidosis 63 Commonly prescribed 63 BrachySil TM 63 cystoid macular edema 63 intestinal mucosal 63 neurohormonal activation 63 receiving immunosuppressive therapy 63 infraspinatus 63 transplantation HCT 63 ischemic mitral regurgitation 63 BCG refractory carcinoma 63 Naive Patients 63 systemic toxicity 63 PROCRIT ® 63 hyperglycaemia 63 FluCAM arm 63 Venous thromboembolism 63 genotypic resistance 63 carotid atherosclerosis 63 docetaxel Taxotere ® 63 immunopathology 63 hyperacute 63 Hemorrhagic stroke 63 GI motility 63 microvascular disease 63 non metastatic osteosarcoma 63 response CCyR 63 oxycodone CR 63 mGluR2 NAM 63 demyelinating disease 63 Vidofludimus 63 Lixivaptan 63 serum lipid levels 63 sensory neuropathy 63 cAMP signaling 63 neutropenic sepsis 63 Patency 63 Pseudomonas aeruginosa infections 63 fever skin rashes 63 Chlamydia trachomatis infection 63 choroidal neovascularization CNV 63 dizziness nausea confusion 63 interferon ribavirin 63 node metastases 63 glucocorticoid therapy 63 degranulation 63 infective endocarditis 63 plasma pharmacokinetics 63 tumor regressions 63 vasogenic edema 63 steroid dexamethasone 63 Peripheral Arterial 63 hepatic failure 63 NMIBC 63 detrusor overactivity 63 EDEMA3 trial 63 IOP lowering 63 Prolongs Survival 63 Flu Cy 63 lupus anticoagulant 63 RoACTEMRA 63 Hypertrophic 63 arterial inflammation 63 β blocker 63 suppurative 63 delayed onset CINV 63 lucinactant 63 decompensated heart failure 63 urate levels 63 calculated creatinine clearance 63 lipohypertrophy 63 neurologic deficits 63 pancreatic prostate 63 hypocalcemia 63 acetabular dysplasia 63 transcranial Doppler ultrasound 63 Endothelial function 63 light headedness dizziness 63 Fondaparinux 63 Thromboembolism 63 hepatocellular carcinoma liver 63 pathologic fractures 63 periventricular leukomalacia 63 EpCAM expression 63 complete cytogenetic response 63 NATRECOR ® 63 Chronic renal failure 63 angiographic outcomes 63 dysuria 63 extrapyramidal symptoms EPS 63 myalgia arthralgia 63 Triapine R 63 Catena ® 63 nephropathy kidney 63 INFERGEN 63 debilitating complication 63 solifenacin 63 brivaracetam 63 salmeterol HFA MDI 63 Pharmacokinetics PK 63 vidofludimus 63 Hyperlipidemia 63 LAB CGRP 63 arterial revascularization 63 extraocular 63 postoperative delirium 63 immunosuppressed patients 63 STAT3 signaling 63 Thal Dex 63 familial hypercholesterolemia FH 63 gastrointestinal motility 63 cMET 63 diabetic microvascular complications 63 Exacerbation 63 Heterozygous Familial Hypercholesterolemia 63 hemagglutination inhibition HAI 63 post herpetic 63 Immune reconstitution syndrome 63 extramedullary 63 idiopathic thrombocytopenic purpura 63 β blockers 63 esophageal gastric 63 elevated IOP 63 postprocedure 63 Decitabine 63 mucociliary clearance 63 liposomal amphotericin B 63 chorioamnionitis 63 CYP#D# inhibitor 63 rhinitis sinusitis 63 fatigue headache nausea 63 conjunctival hyperemia 63 PR interval prolongation 63 dots petechiae 63 Primary endpoints 63 thromboembolic 63 Intracoronary 63 nausea emesis 63 retinal thickness 63 urate lowering 63 gastrointestinal stromal tumors GIST 63 Unstable Angina 63 STRATEGY FOR AN OPEN 63 contrast echocardiography 63 ADAMTS# 63 elevated triglyceride levels 63 exploratory endpoints 63 somatostatin analog 63 esophageal candidiasis 63 Leukemias 63 non splenectomized 63 Duodenal 63 Teriflunomide 63 Diffuse Large B 63 lumbar spine bone 63 Demonstrated Significant 63 fallopian tube cancers 63 Denufosol 63 prostate carcinoma 63 cortical atrophy 63 hepatic insufficiency 63 active ankylosing spondylitis 63 adrenal insufficiency 63 Vidaza ® 63 Myelosuppression 63 Hypertrophy 63 Acute Decompensated Heart Failure 63 Cardiotoxicity 63 inflammatory biomarkers 63 probiotic supplementation 63 esophageal perforation 63 overactive bladder symptoms 63 transaminases 63 paroxysmal nocturnal hemoglobinuria 63 constipating effects 63 incidence ≥ 63 myelosuppression 63 serum BDNF 63 galiximab 63 undergoing elective percutaneous 63 hemorrhagic cerebrovascular events 63 adalimumab Humira 63 vascular permeability 63 ximelagatran 63 Claudication 63 glial tumors 63 bFGF 63 alfa 2a 63 dilated cardiomyopathy DCM 63 splenic 63 affective psychosis 63 leiomyomas 63 ANAVEX #-# [001] 63 culture supernatants 63 mitral regurgitation MR 63 unfavorable cytogenetics 63 inflammatory lesions 63 somatosensory evoked potentials 63 metformin accumulation 63 corrected QT interval 63 chronic periodontitis 63 nausea diarrhea fatigue 63 ispinesib administered 63 potently inhibited 63 distal embolization thrombus formation 63 nonalcoholic steatohepatitis NASH 63 weekly subcutaneous injections 63 prednisone prednisolone 63 opioid analgesia 63 hypercalcemia 63 neutrophil count 63 blood glucose concentrations 63 Subarachnoid hemorrhage 63 B7 H3 63 Escherichia coli Klebsiella pneumoniae 63 vitamin B# folic acid 63 morbidity mortality 63 Beta catenin pathway 63 C1 INH deficiency 63 PCNSL 63 cardiac contractility 63 immune thrombocytopenic purpura 63 bony metastases 63 vapreotide acetate 63 vertigo dizziness 63 hemodynamically unstable 63 malignancy HCM 63 hyperoxaluria 63 nucleotide analog 63 serum triglycerides 63 Prostatitis 63 neointimal 63 asthma rhinitis 63 Cell Lymphoma 63 intraventricular 63 neonatal morbidity 63 Virologic 63 Achieves Primary Endpoint 63 CTAP# 63 Lupus nephritis 63 pruritus itching 63 liver enzymes ALT 63 neuronal dysfunction 63 triiodothyronine 63 Mg Usa 63 headaches dizziness disorientation nausea 63 extracellular dopamine 63 opioid induced 63 Hydroxyurea 63 granulomatous 63 femoral neck fracture 63 pDC 63 ORENCIA R 63 dose dependently 63 variceal hemorrhage 63 N. gonorrhoeae 63 cramping abdominal pain 63 nonsevere 63 vecuronium 63 herpetic 63 Glucocorticoids 63 R entecavir 63 decompensated cirrhosis 63 purpura ITP 63 opioid naive 63 choroidal 63 Skeletal Muscle 63 antiangiogenic therapy 63 precancerous cervical 63 hepatic renal 63 bronchodilatory 63 intestinal permeability 63 venous hypertension 63 macular edema secondary 63 salivary flow 63 oral anticoagulant therapy 63 adrenalectomy 63 Obstructive sleep apnea OSA 63 gonococcal 63 lung metastasis 63 forodesine 63 lowering blood glucose 63 intrathoracic 63 NAVISTAR R 63 ischemic complications 63 elevated uric acid 63 postoperative bleeding 63 diarrhea colitis 63 Mucositis 63 Negative Symptoms 63 recombinant PSMA vaccine 63 coronary insufficiency

Back to home page